Viemed Q2 2026 revenue $78.1M record, up 23.9% YoY; raises FY revenue guidance

VIEMED HEALTHCARE, INC.

Net revenue $78.1M (record), up 23.9% YoY; net income $2.8M ($0.07 diluted EPS).
Adjusted EBITDA $13.7M, down 4% YoY due to prior-year non-recurring gain of $1.0M.
Ventilator patients 12,635 (+4% YoY); PAP therapy patients 37,825 (+44% YoY).
Repurchased 530,802 shares at avg $9.65 for $5.1M in Q2.
FY 2026 revenue guidance raised to $314-320M (prev $312-320M); Adj. EBITDA guidance narrowed to $64-68M (prev $65-69M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.